CCMH
UTHR icon

Cornerstone Capital Management Holdings’s United Therapeutics UTHR Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$20.3M Buy
137,508
+41,731
+44% +$5.31M 0.14% 162
2017
Q3 		$11.2M Sell
95,777
-36,113
-27% -$4.61M 0.09% 260
2017
Q2 		$17.1M Sell
131,890
-72,287
-35% -$9.02M 0.13% 176
2017
Q1 		$27.6M Buy
204,177
+159,984
+362% +$24.2M 0.21% 98
2016
Q4 		$6.34M Buy
44,193
+7,954
+22% +$1.02M 0.05% 403
2016
Q3 		$4.28M Buy
36,239
+30,354
+516% +$3.65M 0.03% 509
2016
Q2 		$623K Sell
5,885
-14,284
-71% -$1.59M 0.01% 986
2016
Q1 		$2.25M Sell
20,169
-30,542
-60% -$3.86M 0.02% 694
2015
Q4 		$7.94M Sell
50,711
-38,285
-43% -$5.57M 0.07% 328
2015
Q3 		$11.7M Sell
88,996
-15,499
-15% -$2.49M 0.11% 215
2015
Q2 		$18.2M Sell
104,495
-15,663
-13% -$2.82M 0.16% 142
2015
Q1 		$20.7M Sell
120,158
-24,783
-17% -$3.78M 0.19% 122
2014
Q4 		$18.8M Buy
144,941
+11,700
+9% +$1.51M 0.19% 132
2014
Q3 		$17.1M Sell
133,241
-47,432
-26% -$4.89M 0.19% 147
2014
Q2 		$16M Buy
180,673
+19,208
+12% +$1.85M 0.18% 155
2014
Q1 		$15.2M Buy
161,465
+13,648
+9% +$1.4M 0.18% 157
2013
Q4 		$16.7M Sell
147,817
-21,097
-12% -$1.9M 0.19% 139
2013
Q3 		$13.3M Sell
168,914
-14,860
-8% -$1.09M 0.16% 175
2013
Q2 		$12.1M Buy
+183,774
New +$11.8M 0.15% 172

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cornerstone Capital Management Holdings's UTHR Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its United Therapeutics (UTHR) stake by 44% in Q4 2017, buying an estimated $5.31M and bringing the position to 137,508 shares worth $20.3M. The position accounts for 0.14% of the portfolio, ranked #162.

Cornerstone Capital Management Holdings first reported a position in UTHR in Q2 2013 and has held it in 19 quarters since. The position peaked at $27.6M in Q1 2017. 400 funds tracked by Wall St. Rank hold UTHR as of Q4 2017.

  • Cornerstone Capital Management Holdings held 137,508 shares of United Therapeutics worth $20.3M as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 41,731 United Therapeutics shares in Q4 2017, an estimated $5.31M.
  • United Therapeutics made up 0.14% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #162 holding.
  • Cornerstone Capital Management Holdings first reported a position in United Therapeutics in Q2 2013 and has held it in 19 quarters since.
  • Cornerstone Capital Management Holdings's United Therapeutics position peaked at $27.6M in Q1 2017.
  • 400 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.